|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.815 USD | +6.30% |
|
-4.52% | -80.22% |
| 06-20 | Transcript : PAVmed Inc. - Shareholder/Analyst Call | |
| 05-14 | Transcript : PAVmed Inc., Q1 2024 Earnings Call, May 14, 2024 |
PAVmed Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 1.01 million compared to USD 0.446 million a year ago. Net loss was USD 15.21 million compared to USD 17.93 million a year ago.
Basic loss per share from continuing operations was USD 2.62 compared to USD 2.78 a year ago. Diluted loss per share from continuing operations was USD 2.62 compared to USD 2.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -80.22% | 7.23M | |
| +4.18% | 210B | |
| +8.00% | 186B | |
| +31.86% | 158B | |
| +33.21% | 113B | |
| +2.28% | 66.13B | |
| +21.14% | 56.25B | |
| +0.11% | 49B | |
| -6.76% | 38.16B | |
| +0.78% | 35.98B |
PAVMED INC. 
